Dual activating TDD
First Claim
1. A novel transdermal delivery device for ensuring longer shelf life of unstable drugs comprising a patch for disbursement of therapeutic drugs to the skin of a user;
- said patch comprising an inbuilt injection port in which the user injects the diluent and/or active ingredient(s) into the drug reservoir to activate said drug delivery device, wherein the device has a varied permeable rate-controlling membrane to accommodate the specific drug being introduced to the device, wherein upon removing the protective outer layer, of the preferred embodiment FIG. 1. the device is ready to be placed on the skin by the patient.
0 Assignments
0 Petitions
Accused Products
Abstract
Preferred embodiment FIG. 1, comprises a novel transdermal delivery device for ensuring longer shelf life of unstable drugs comprising a patch for disbursement of therapeutic drugs to the skin of a user; said patch comprising an inbuilt injection port in which the user injects the diluent and/or active ingredient(s) into the drug reservoir to activate said drug delivery device, wherein the device comprises various permeablity rate-controlling membranes to accommodate a specific drug being introduced to the device, wherein upon removing the protective outer layer, of the preferred embodiment FIG. 1. the device is ready to be placed on the skin by the patient. Additional embodiment replaces the injection port with a separate sealed diluent pouch reservoir.
-
Citations
10 Claims
-
1. A novel transdermal delivery device for ensuring longer shelf life of unstable drugs comprising a patch for disbursement of therapeutic drugs to the skin of a user;
- said patch comprising an inbuilt injection port in which the user injects the diluent and/or active ingredient(s) into the drug reservoir to activate said drug delivery device, wherein the device has a varied permeable rate-controlling membrane to accommodate the specific drug being introduced to the device, wherein upon removing the protective outer layer, of the preferred embodiment
FIG. 1 . the device is ready to be placed on the skin by the patient. - View Dependent Claims (3, 6)
- said patch comprising an inbuilt injection port in which the user injects the diluent and/or active ingredient(s) into the drug reservoir to activate said drug delivery device, wherein the device has a varied permeable rate-controlling membrane to accommodate the specific drug being introduced to the device, wherein upon removing the protective outer layer, of the preferred embodiment
-
2. Additional Embodiment of the present invention comprising;
- said patch including a separate sealed pouch component comprising a liquid diluent within the active ingredient(s) reservoir, represented in embodiment 2 of the present invention;
wherein the user must apply between 10-30 pounds of pressure to burst said diluent pouch to mix the active ingredient(s), wherein said active ingredient(s) migrate through a permeable rate-controlling membrane to the surface of the patch, wherein the user must remove the protective outer layer before attaching said patch to the skin. - View Dependent Claims (4, 7, 8, 9)
- said patch including a separate sealed pouch component comprising a liquid diluent within the active ingredient(s) reservoir, represented in embodiment 2 of the present invention;
-
5. An additional embodiment,
FIG. 2 ;- comprises a separate sealed pouch reservoir wherein the diluent is stored within the active ingredient(s) reservoir layer 3 of the device;
- comprises a separate sealed pouch reservoir wherein the diluent is stored within the active ingredient(s) reservoir layer 3 of the device;
-
10. Another aspect of the present invention wherein;
- the transdermal delivery device will be worn by the patient for predetermined amount of time from 4 to 24 hours or longer;
- the transdermal delivery device will be worn by the patient for predetermined amount of time from 4 to 24 hours or longer;
Specification